Gujarat Themis Biosyn Limited (GUJTHEM) — Insider Trading | 4 August 2026

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Promoter Sachin D. Patel acquires 5,23,560 shares through inter-se transfer.
🔄 What Changed
Post-acquisition shareholding increased to 2.77% from 2.29%; seller's stake decreased to 46.54% from 47.02%.
💡 Investor Takeaway
This transaction adjusts promoter ownership but does not signal new capital deployment or strategic shift.

Sachin D. Patel disclosed acquisition of 5,23,560 shares in Gujarat Themis Biosyn Limited via inter-se transfer between promoters, exempt from open offer under SEBI SAST Regulations. The transaction increased his post-acquisition holding to 2.77% from 2.29%, while the seller's stake reduced slightly to 46.54% from 47.02%. The filing confirms compliance with disclosure timelines and regulatory exemptions.

📄 View Original Announcement (PDF)

About Gujarat Themis Biosyn Limited (GUJTHEM)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹4,570.55 Cr

View full GUJTHEM stock details →

📡 Get AI alerts when GUJTHEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track GUJTHEM — Free

📊 More GUJTHEM filings

See all GUJTHEM filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when GUJTHEM files new disclosures

Track GUJTHEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track GUJTHEM — Free

Free account · 2 AI queries/day